Chen NG - Search Results

1

Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.

Park AK, Fong Y, Kim SI, Yang J, Murad JP, Lu J, Jeang B, Chang WC, Chen NG, Thomas SH, Forman SJ, Priceman SJ. Park AK, et al. Among authors: chen ng. Sci Transl Med. 2020 Sep 2;12(559):eaaz1863. doi: 10.1126/scitranslmed.aaz1863. Sci Transl Med. 2020. PMID: 32878978 Free PMC article.

2

Novel chimeric parapoxvirus CF189 as an oncolytic immunotherapy in triple-negative breast cancer.

Choi AH, O'Leary MP, Chaurasiya S, Lu J, Kim SI, Fong Y, Chen NG. Choi AH, et al. Among authors: chen ng. Surgery. 2018 Feb;163(2):336-342. doi: 10.1016/j.surg.2017.09.030. Epub 2017 Nov 22. Surgery. 2018. PMID: 29174433 Free PMC article.

3

Oncolytic viruses and immunity.

Chaurasiya S, Chen NG, Fong Y. Chaurasiya S, et al. Among authors: chen ng. Curr Opin Immunol. 2018 Apr;51:83-90. doi: 10.1016/j.coi.2018.03.008. Epub 2018 Mar 16. Curr Opin Immunol. 2018. PMID: 29550660 Free PMC article. Review.

4

Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.

O'Leary MP, Choi AH, Kim SI, Chaurasiya S, Lu J, Park AK, Woo Y, Warner SG, Fong Y, Chen NG. O'Leary MP, et al. Among authors: chen ng. J Transl Med. 2018 Apr 26;16(1):110. doi: 10.1186/s12967-018-1483-x. J Transl Med. 2018. PMID: 29699566 Free PMC article.

5

Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer.

Choi AH, O'Leary MP, Lu J, Kim SI, Fong Y, Chen NG. Choi AH, et al. Among authors: chen ng. Mol Ther Oncolytics. 2018 Apr 5;9:22-29. doi: 10.1016/j.omto.2018.04.001. eCollection 2018 Jun 29. Mol Ther Oncolytics. 2018. PMID: 29988465 Free PMC article.

6

A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection.

O'Leary MP, Warner SG, Kim SI, Chaurasiya S, Lu J, Choi AH, Park AK, Woo Y, Fong Y, Chen NG. O'Leary MP, et al. Among authors: chen ng. Mol Ther Oncolytics. 2018 Mar 22;9:13-21. doi: 10.1016/j.omto.2018.03.001. eCollection 2018 Jun 29. Mol Ther Oncolytics. 2018. PMID: 29988502 Free PMC article.

7

A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models.

Chaurasiya S, Chen NG, Lu J, Martin N, Shen Y, Kim SI, Warner SG, Woo Y, Fong Y. Chaurasiya S, et al. Among authors: chen ng. Cancer Gene Ther. 2020 Apr;27(3-4):125-135. doi: 10.1038/s41417-019-0114-x. Epub 2019 Jun 17. Cancer Gene Ther. 2020. PMID: 31209267 Free PMC article.

8

From Benchtop to Bedside: A Review of Oncolytic Virotherapy.

Choi AH, O'Leary MP, Fong Y, Chen NG. Choi AH, et al. Among authors: chen ng. Biomedicines. 2016 Aug 2;4(3):18. doi: 10.3390/biomedicines4030018. Biomedicines. 2016. PMID: 28536385 Free PMC article. Review.

9

A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression.

Warner SG, Kim SI, Chaurasiya S, O'Leary MP, Lu J, Sivanandam V, Woo Y, Chen NG, Fong Y. Warner SG, et al. Among authors: chen ng. Mol Ther Oncolytics. 2019 Apr 11;13:82-92. doi: 10.1016/j.omto.2019.04.001. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 31061881 Free PMC article.

10

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds.

Sivanandam V, LaRocca CJ, Chen NG, Fong Y, Warner SG. Sivanandam V, et al. Among authors: chen ng. Mol Ther Oncolytics. 2019 Apr 25;13:93-106. doi: 10.1016/j.omto.2019.04.003. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 31080879 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page